SGH Health Glossary
Teaching & Research Activities

Print friendly version   print friendly version

Pulmonary Rehabilitation Programme

Rehabilitation Centre
Block 3, Level 1
Tel : 321 4132
Fax : 326 5495


What is Pulmonary Rehabilitation ?
Pulmonary Rehabilitation is a multidimensional continuum of services directed to persons with pulmonary disease and their families, usually by an interdisciplinary team of specialists, with the goal of achieving and maintaining the individual’s maximum level of independence and functioning in the community.

Why Pulmonary Rehabilitation?
Many patients with chronic respiratory disorders e.g. chronic obstructive pulmonary disease (COPD) are physically deconditioned as a result of abstinence from physical activity. These patients are caught in a downward spiral resulting eventually in total incapacitation and dyspnea at rest. Hence, even though the underlying respiratory disorder has received optimal drug therapy, many such patients remain dyspneic, with poor effort tolerance and quality of life. Pulmonary Rehabilitation has been shown to improve the symptom of dyspnea and quality of life in patients with COPD. Exercise training is also recommended in the management of these patients.

SGH Pulmonary Rehabilitation Program (PRP)
The SGH PRP is a 6 week program with a 4 day initial inpatient evaluation followed by thrice weekly outpatient sessions. The program includes supervised exercise training, breathing exercises, education sessions and discussion groups. Objective testing including pulmonary function tests, cardiopulmonary exercise tests, 6 minute walk tests will be performed at the beginning and at the end of the program to evaluate response. Entry into the program requires evaluation by an SGH Respiratory Physician.

Who will benefit?
Patients with chronic obstructive pulmonary disease including chronic bronchitis, emphysema can be considered for PRP if they

  • Have completely stopped smoking for at least 3 months
  • Are self-ambulant with or without walking aids

Patients with other forms of chronic lung diseases e.g. bronchiectasis and restrictive lung diseases may be considered for PRP on a case-by-case basis.
After completion of the 6 week PRP, patients will be followed up for a maximum of 3 months after which all patients will be referred back to the referral source.